GHRP-2 Effectively Stimulates Growth Hormone Release Even in Critically Ill Patients
In critically ill patients with blunted GH secretion, GHRP-2 maintained the ability to stimulate GH release, offering a potential strategy to combat the protein wasting and hormonal disruption of critical illness.
Quick Facts
What This Study Found
GHRP-2 maintained GH-releasing efficacy in critically ill patients despite blunted responses to GHRH, suggesting a preserved alternative pathway for GH stimulation.
Key Numbers
How They Did This
Clinical study testing pituitary GH responses to GHRH, GHRP-2, and TRH in critically ill patients, comparing to expected normal responses.
Why This Research Matters
Muscle wasting in ICU patients significantly impacts recovery. If GHRP-2 can stimulate GH release when normal pathways are suppressed, it could help preserve muscle mass during critical illness.
The Bigger Picture
This study contributed to understanding how the GH axis is disrupted in critical illness and identified GHRP-2 as a potential intervention to combat ICU-related muscle wasting and metabolic dysfunction.
What This Study Doesn't Tell Us
Clinical study in critically ill patients — a heterogeneous population. Sample size and specific response magnitudes not detailed in abstract. Functional outcomes not assessed.
Questions This Raises
- ?Could GHRP-2 treatment reduce muscle wasting and improve outcomes in ICU patients?
- ?Should GH secretagogues be part of standard ICU endocrine management?
Trust & Context
- Key Stat:
- GHRP-2 works in critical illness Unlike GHRH, GHRP-2 maintained its GH-releasing ability even when the GH axis was suppressed by critical illness
- Evidence Grade:
- Moderate clinical evidence from a study in critically ill patients. Demonstrates preserved GHRP-2 responsiveness but lacks outcome data.
- Study Age:
- Published in 1996, this study highlighted GHRP-2's potential in critical care, an application area still under investigation.
- Original Title:
- Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
- Published In:
- Clinical endocrinology, 45(3), 341-51 (1996)
- Authors:
- Van den Berghe, G(10), de Zegher, F(5), Bowers, C Y(21), Wouters, P, Muller, P, Soetens, F, Vlasselaers, D, Schetz, M, Verwaest, C, Lauwers, P, Bouillon, R
- Database ID:
- RPEP-00391
Evidence Hierarchy
Frequently Asked Questions
Why is GH important in critical illness?
Growth hormone promotes protein synthesis and muscle preservation. In critical illness, GH secretion drops dramatically, contributing to severe muscle wasting that delays recovery and increases complications.
Why does GHRP-2 still work when GHRH doesn't?
GHRP-2 and GHRH work through completely different receptors and pathways. In critical illness, the GHRH pathway is suppressed, but the GHRP/ghrelin receptor pathway remains functional, allowing GHRP-2 to bypass the blockade.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00391APA
Van den Berghe, G; de Zegher, F; Bowers, C Y; Wouters, P; Muller, P; Soetens, F; Vlasselaers, D; Schetz, M; Verwaest, C; Lauwers, P; Bouillon, R. (1996). Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.. Clinical endocrinology, 45(3), 341-51.
MLA
Van den Berghe, G, et al. "Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.." Clinical endocrinology, 1996.
RethinkPeptides
RethinkPeptides Research Database. "Pituitary responsiveness to GH-releasing hormone, GH-releasi..." RPEP-00391. Retrieved from https://rethinkpeptides.com/research/van-1996-pituitary-responsiveness-to-ghreleasing
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.